News | May 29, 2026
AbbVie wins FDA nod for DECNUPAZ in rare blood cancer
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
The new facility marks Align’s first manufacturing presence in India and its fourth globally
A one-shot gene-editing cholesterol therapy could soon be a reality
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
Clearance marks major shift beyond chemotherapy
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
